A case report of a 73-year-old man with Leprosy from Zambia

One of the leading causes of disability among infectious diseases is leprosy. Despite achieving the World Health Organisation (WHO) target for leprosy control, leprosy is still eminent in Zambia as well as in many other endemic regions such as West Africa and Asia-Pacific. It is evident that published numbers pertaining to prevalence may not give accurate values of prevalence on the ground due to factors such as loss of follow-up as leprosy patients often face stigma, hence poor healthcare seeking behaviour, patient exclusion from community, and barriers in research funding. A 73-year-old male was admitted to the University Teaching Hospital with a history of long-standing wounds involving fingers and toes, which he described as painless. Physical examination revealed deformed feet and hands with no sensation on palpation. A skin biopsy was positive for Mycobacterium leprae. Based on the extent of distribution of the lesion, the patient was classified with a multibacillary subtype. Multidrug regimen treatment with dapsone, clofazimine, and rifampicin was initiated. This case is evidence that leprosy is still present in our community, and delays in diagnosis and treatment usually lead to debilitating outcomes.

Authors

Institutions

Publication Details

Journal
Medical Journal of Zambia
Published
2025-03-15
DOI
https://doi.org/10.55320/mjz.52.2.629
Primary Topic
Leprosy Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A case report of a 73-year-old man with Leprosy from Zambia

Mwansa Ketty Lubeya, Therese Shema Nzayisenga, Muhammed Mputu
Medical Journal of Zambia
Leprosy Research and Treatment
article

A case report of a 73-year-old man with Leprosy from Zambia

Mwansa Ketty Lubeya, Therese Shema Nzayisenga, Muhammed Mputu
article en

Abstract

One of the leading causes of disability among infectious diseases is leprosy. Despite achieving the World Health Organisation (WHO) target for leprosy control, leprosy is still eminent in Zambia as well as in many other endemic regions such as West Africa and Asia-Pacific. It is evident that published numbers pertaining to prevalence may not give accurate values of prevalence on the ground due to factors such as loss of follow-up as leprosy patients often face stigma, hence poor healthcare seeking behaviour, patient exclusion from community, and barriers in research funding. A 73-year-old male was admitted to the University Teaching Hospital with a history of long-standing wounds involving fingers and toes, which he described as painless. Physical examination revealed deformed feet and hands with no sensation on palpation. A skin biopsy was positive for Mycobacterium leprae. Based on the extent of distribution of the lesion, the patient was classified with a multibacillary subtype. Multidrug regimen treatment with dapsone, clofazimine, and rifampicin was initiated. This case is evidence that leprosy is still present in our community, and delays in diagnosis and treatment usually lead to debilitating outcomes.

Medical Journal of ZambiaVol. 52(2)
University of Zambia (ZM)
Openalex Percentile: Top 67%
Leprosy Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.